Stoke Therapeutics Inc (STOK)

May 22, 2026

UBS Group AG Decreases Stock Position in Stoke Therapeutics, Inc. $STOK - MarketBeat

May 22, 2026

May 21, 2026

Nathan Lee Starts New Role as Vice President, Commercial Manufacturing at Stoke Therapeutics - hrtoday.in

May 21, 2026

May 21, 2026

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? - TradingView

May 21, 2026

May 20, 2026

Stoke Therapeutics (STOK) Is Down 7.8% After Sharp Q1 Swing From Profit To Loss – What's Changed - simplywall.st

May 20, 2026

May 19, 2026

Zorevunersen tied to long-term benefits in Dravet syndrome - Dravet Syndrome News

May 19, 2026

May 18, 2026

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)May 18, 2026 - BioSpace

May 18, 2026

May 18, 2026

Lynx1 (STOK) files 13G/A reporting 4.76M shares, 8.1% stake - Stock Titan

May 18, 2026

May 17, 2026

Technical Reactions to STOK Trends in Macro Strategies - Stock Traders Daily

May 17, 2026

May 16, 2026

Stoke Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

May 16, 2026

May 16, 2026

Stoke Therapeutics (STOK): Analyst Ratings and Price Target Upda - GuruFocus

May 16, 2026

May 15, 2026

Lynx1 Capital discloses 4.12M shares of Stoke Therapeutics (STOK) - Stock Titan

May 15, 2026

May 15, 2026

Redmile Group reports 4.16M shares in Stoke Therapeutics (STOK) - Stock Titan

May 15, 2026

May 15, 2026

TD Bank (NASDAQ: STOK) reports 3.18M shares, 5.4% stake - Stock Titan

May 15, 2026

May 15, 2026

RTW Funds and R. Wong report 9.99% stake in Stoke Therapeutics (STOK) - Stock Titan

May 15, 2026

May 15, 2026

Wellington affiliates hold 3.1M shares in Stoke Therapeutics (STOK) - Stock Titan

May 15, 2026

May 14, 2026

We're Not Very Worried About Stoke Therapeutics' (NASDAQ:STOK) Cash Burn Rate - Moomoo

May 14, 2026

May 13, 2026

HC Wainwright Analysts Boost Earnings Estimates for STOK - MarketBeat

May 13, 2026

May 12, 2026

Stoke outlines Q1 2027 rolling NDA start as EMPEROR enrollment targets June, backed by $411M cash balance - MSN

May 12, 2026

May 11, 2026

Stoke Therapeutics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:STOK) 2026-05-11 - Seeking Alpha

May 11, 2026

May 11, 2026

BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $39 - Moomoo

May 11, 2026

May 11, 2026

Stoke Therapeutics, Inc. (NASDAQ:STOK) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st

May 11, 2026

May 11, 2026

Stoke Therapeutics' (STOK) "Buy" Rating Reiterated at BTIG Research - MarketBeat

May 11, 2026

May 11, 2026

STOK Reiterates by BTIG -- Price Target Maintained at $39.00 - GuruFocus

May 11, 2026

May 09, 2026

Guggenheim Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $60 - Moomoo

May 09, 2026

May 09, 2026

A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $38 to $60 - Moomoo

May 09, 2026

May 09, 2026

Stoke Therapeutics Q1 Earnings Call Highlights - MarketBeat

May 09, 2026

May 08, 2026

Stoke Therapeutics (NASDAQ:STOK) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

May 08, 2026

May 08, 2026

Stoke Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 08, 2026

May 08, 2026

Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates - BioSpace

May 08, 2026

May 08, 2026

Transcript : Stoke Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com

May 08, 2026

May 07, 2026

Stoke Therapeutics Q1 2026 slides show zorevunersen Phase 3 progress By Investing.com - Investing.com Canada

May 07, 2026

May 07, 2026

Earnings call transcript: Stoke Therapeutics Q1 2026 results show mixed performance By Investing.com - Investing.com South Africa

May 07, 2026

May 07, 2026

Earnings call transcript: Stoke Therapeutics Q1 2026 results show mixed performance - Investing.com Nigeria

May 07, 2026

May 07, 2026

Stoke Therapeutics (NASDAQ:STOK) Beats Q1 2026 Estimates as Phase 3 Trial Nears Completion - ChartMill

May 07, 2026

May 07, 2026

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2026

May 07, 2026

Why Stoke Therapeutics Stock Is Sliding Hard Today - TipRanks

May 07, 2026

May 07, 2026

STOKE THERAPEUTICS Q1 EPS USD -0.79 - Moomoo

May 07, 2026

May 07, 2026

Earnings Flash (STOK) Stoke Therapeutics, Inc. Reports Q1 Revenue $6.2M, vs. FactSet Est of $6.5M - marketscreener.com

May 07, 2026

May 07, 2026

Stoke Therapeutics (Nasdaq: STOK) Q1 2026 loss, zorevunersen data and cash runway to 2028 - Stock Titan

May 07, 2026

May 07, 2026

Stoke Therapeutics (NASDAQ: STOK) swings to Q1 2026 loss as Biogen upfront revenue rolls off - Stock Titan

May 07, 2026

May 07, 2026

Stoke Therapeutics faces earnings test after revenue miss By Investing.com - Investing.com Nigeria

May 07, 2026

May 07, 2026

Stoke Therapeutics faces earnings test after revenue miss - Investing.com UK

May 07, 2026

May 06, 2026

Trading the Move, Not the Narrative: (STOK) Edition - Stock Traders Daily

May 06, 2026

May 06, 2026

Privium Fund Management B.V. Takes Position in Stoke Therapeutics, Inc. $STOK - MarketBeat

May 06, 2026

May 05, 2026

Insider Sell Alert: Barry Ticho Sells Shares of Stoke Therapeuti - GuruFocus

May 05, 2026

May 05, 2026

Stoke Therapeutics (STOK) CMO sells 2,243 shares in open-market trade - Stock Titan

May 05, 2026